» Articles » PMID: 37239102

Compromised Myelin and Axonal Molecular Organization Following Adult-Onset Sulfatide Depletion

Overview
Journal Biomedicines
Date 2023 May 27
PMID 37239102
Authors
Affiliations
Soon will be listed here.
Abstract

3-O-sulfogalactosylceramide, or sulfatide, is a prominent myelin glycosphingolipid reduced in the normal appearing white matter (NAWM) in Multiple Sclerosis (MS), indicating that sulfatide reduction precedes demyelination. Using a mouse model that is constitutively depleted of sulfatide, we previously demonstrated that sulfatide is essential during development for the establishment and maintenance of myelin and axonal integrity and for the stable tethering of certain myelin proteins in the sheath. Here, using an adult-onset depletion model of sulfatide, we employ a combination of ultrastructural, immunohistochemical and biochemical approaches to analyze the consequence of sulfatide depletion from the adult CNS. Our findings show a progressive loss of axonal protein domain organization, which is accompanied by axonal degeneration, with myelin sparing. Similar to our previous work, we also observe differential myelin protein anchoring stabilities that are both sulfatide dependent and independent. Most notably, stable anchoring of neurofascin155, a myelin paranodal protein that binds the axonal paranodal complex of contactin/Caspr1, requires sulfatide. Together, our findings show that adult-onset sulfatide depletion, independent of demyelination, is sufficient to trigger progressive axonal degeneration. Although the pathologic mechanism is unknown, we propose that sulfatide is required for maintaining myelin organization and subsequent myelin-axon interactions and disruptions in these interactions results in compromised axon structure and function.

Citing Articles

Advanced neuroprosthetic electrode design optimized by electromagnetic finite element simulation: innovations and applications.

Yang S, Yang S, Li P, Gou S, Cheng Y, Jia Q Front Bioeng Biotechnol. 2024; 12:1476447.

PMID: 39574462 PMC: 11579925. DOI: 10.3389/fbioe.2024.1476447.


Dynamics of mature myelin.

Osso L, Hughes E Nat Neurosci. 2024; 27(8):1449-1461.

PMID: 38773349 PMC: 11515933. DOI: 10.1038/s41593-024-01642-2.


From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment.

Raghib M, Bernitsas E Biomedicines. 2023; 11(11).

PMID: 38002068 PMC: 10668955. DOI: 10.3390/biomedicines11113069.


Adult-Onset CNS Sulfatide Deficiency Causes Sex-Dependent Metabolic Disruption in Aging.

Qiu S, He S, Wang J, Wang H, Bhattacharjee A, Li X Int J Mol Sci. 2023; 24(13).

PMID: 37445661 PMC: 10341976. DOI: 10.3390/ijms241310483.

References
1.
Janssen B . Inside-out or outside-in, a new factor in MAG-mediated signaling in the nervous system: An Editorial for 'High-affinity heterotetramer formation between the large myelin-associated glycoprotein and the dynein light chain DYNLL1' on page 764. J Neurochem. 2018; 147(6):712-714. DOI: 10.1111/jnc.14597. View

2.
Doerflinger N, Macklin W, Popko B . Inducible site-specific recombination in myelinating cells. Genesis. 2002; 35(1):63-72. DOI: 10.1002/gene.10154. View

3.
Howell O, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C . Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain. 2006; 129(Pt 12):3173-85. DOI: 10.1093/brain/awl290. View

4.
Chiu S, Zhou L, Zhang C, Messing A . Analysis of potassium channel functions in mammalian axons by gene knockouts. J Neurocytol. 2000; 28(4-5):349-64. DOI: 10.1023/a:1007013731231. View

5.
Knapp P, Skoff R, Sprinkle T . Differential expression of galactocerebroside, myelin basic protein, and 2',3'-cyclic nucleotide 3'-phosphohydrolase during development of oligodendrocytes in vitro. J Neurosci Res. 1988; 21(2-4):249-59. DOI: 10.1002/jnr.490210217. View